Events

Happy Easter!
Wishing you a happy, healthy and peaceful Easter. More
Events

Merry Christmas

Wishing You Good Vibes for Christmas and Every Happiness in the Coming Year 2025! More
Events

30 years of EGIS in Poland

This year, EGIS Polska celebrates its 30th anniversary on the Polish market. On this occasion, we have created an anniversary film that is not only a celebration of our activities, but also proof of how much we have achieved over the years. More
Events

Happy Easter!

Wishing you a season filled with peace, joy and beautiful memories. Happy Easter! More
Egis World
Egis´ products are sold to more than 100 countries.
Our People
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
Innovation
In the 2022/2023 business year, we spent EUR 48 million on research and development
Events
Our highlighted past and future events you shouldn't miss
Egis World
Egis´ products are sold to more than 100 countries.

Csaba Poroszlai is CEO of Egis Pharmaceuticals PLC

Csaba Poroszlai is confirmed CEO of the company by the Board of Directors of Egis. Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer.

More

Three Egis Subsidiaries Among the Best Employers

Following the success of Egis Russia and Egis Polska, we are proud to announce that Egis Praha has also been recognized as Best Employer at Aon Hewitt’s Employee Engagement Survey.

More

Gran Prize - Egis Innovation for Sustainability

Egis has developed a new procedure for the dehalogenation of technological wastewaters. In 2018, the Swedish Chamber of Commerce in Hungary recognized the innovation with the Gran Prize Interdisciplinary Innovative award.

More

Egis Strengthens European Presence in the Biosimilar Area

Hungarian-based Egis Pharmaceuticals PLC signed an exclusive distribution agreement with Mundipharma network for a pegfilgrastim biosimilar. Pursuant to the agreement, Egis gains the exclusive distribution rights related to the medicine used to reduce a common side effect of cancer treatment called neutropenia and the related life-threatening infections. Thus, Egis gets the opportunity to launch this pegfilgrastim biosimilar product in four Eastern European countries.

More
More articles on Egis World (4)
Our People
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life

Interview with István Hodász (CEO EGIS) on PharmaBoardroom

PharmaBoardroom is a site for senior professionals, providing global news, trends and reports relating to the pharmaceutical industry.

More
More articles on Our People (1)
Innovation
In the 2022/2023 business year, we spent EUR 48 million on research and development

International Digital Idea Challenge EGIS

EGIS Polska team among 5 winners of the first edition of International Digital Idea Challenge EGIS.

More
More articles on Innovation (1)
Events
Our highlighted past and future events you shouldn't miss

Merry Christmas

May the spirit of Christmas bring you peace, love and happiness. Merry Christmas and Happy New Year!

More

Happy Easter

May this joyful season of Easter fill your heart with renewed hope, love and peace. Happy Easter!

More

Celebrating our company’s 110th anniversary

The predecessor of Egis Pharmaceuticals PLC, Dr Wander Pharmaceuticals and Nutriments Ltd. was registered on 19 February 1913.

More

May the spirit of Christmas bring you peace, love and happiness. Merry Christmas and Happy New Year!

More
More articles on Events (17)

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox